Effective Jan. 1, 2018 four opioids are added to the DOT's drug-testing panel for safety-sensitive positions. Those opioids include hydrocodone, hydromorphone, oxymorphone and oxycodone. In addition, labs must add methylenedioxyamphetamine (MDA) as an initial test analyte and remove methylenedioxyethylamphetamine (MDEA) as a confirmatory test analyte.
Bold labels are required.
Brock Law Offices
5625 O Street, Suite 109
Lincoln,
NE
68510
Phone:
402-327-1777
Fax:
402-467-3304
Lincoln Law Office Map
